List of Revvity Signals Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Old Product New Product Category When SI
Axxam Life Sciences 200 $32M Italy Revvity Legacy Revvity Signals Clinical Trial Management,Laboratory Management 2025 n/a
Camurus Life Sciences 250 $66M Sweden Revvity Legacy Revvity Signals Clinical Trial Management,Laboratory Management 2023 n/a
Eli Lilly Life Sciences 47000 $45.0B United States Revvity Legacy Revvity Signals Clinical Trial Management,Laboratory Management 2025 n/a
Life Sciences 28000 $7.0B United States Revvity Legacy Revvity Signals Clinical Trial Management,Laboratory Management 2025 n/a
Life Sciences 350 $55M United States Revvity Legacy Revvity Signals Clinical Trial Management,Laboratory Management 2025 n/a
Showing 1 to 5 of 5 entries

Buyer Intent: Companies Evaluating Revvity Signals

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Revvity Signals. Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Revvity Signals Coverage

Revvity Signals is a Clinical Trial Management, Laboratory Management solution from Revvity.

Companies worldwide use Revvity Signals, from small firms to large enterprises across 21+ industries.

Organizations such as Eli Lilly, MilliporeSigma, Camurus, SK Life Science and Axxam are recorded users of Revvity Signals for Clinical Trial Management, Laboratory Management.

Companies using Revvity Signals are most concentrated in Life Sciences, with adoption spanning over 21 industries.

Companies using Revvity Signals are most concentrated in United States, Sweden and Italy, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Revvity Signals across Americas, EMEA, and APAC.

Companies using Revvity Signals range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 60%, large organizations with 1,001-10,000 employees - 0%, and global enterprises with 10,000+ employees - 40%.

Customers of Revvity Signals include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Revvity Signals customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Clinical Trial Management, Laboratory Management.